2019 HCPCS Codes > Q Codes >

Q2042

Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

  • 2019 Status Change: Add procedure or modifier code
  • Effective Date: 2019-01-01
  • Medicare Coverage Status: Carrier Judgement
  • BETOS Classification: Other drugs

Medicare has not assigned a fee schedule for this code

Q2041       Q2043